Bimodal regulation of the human H1 histamine receptor by G protein-coupled receptor kinase 2

被引:70
作者
Iwata, K
Luo, JS
Penn, RB
Benovic, JL
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA
[2] Wake Forest Univ, Dept Med, Winston Salem, NC 27157 USA
关键词
D O I
10.1074/jbc.M408834200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The H1 histamine receptor (H1HR) is a member of the G protein-coupled receptor superfamily and regulates numerous cellular functions through its activation of the G(q/11) subfamily of heterotrimeric G proteins. Although the H1HR has been shown to undergo desensitization in multiple cell types, the mechanisms underlying the regulation of H1HR signaling are poorly defined. To address this issue, we examined the effects of wild type and mutant G protein-coupled receptor kinases (GRKs) on the phosphorylation and signaling of human H1HR in HEK293 cells. Overexpression of GRK2 promoted H1HR phosphorylation in intact HEK293 cells and completely inhibited inositol phosphate production stimulated by H1HR, whereas GRK5 and GRK6 had lesser effects on H1HR phosphorylation and signaling. Interestingly, catalytically inactive GRK2 (GRK2-K220R) also significantly attenuated H1HR-mediated inositol phosphate production, as did an N-terminal fragment of GRK2 previously characterized as a regulator of G protein signaling (RGS) protein for Galpha(q/11). Disruption of this RGS function in holo-GRK2 by mutation (GRK2-D110A) partially reversed the quenching effect of GRK2, whereas deletion of both the kinase activity and RGS function (GRK2-D110A/K220R) effectively relieved the inhibition of inositol phosphate generation. To evaluate the role of endogenous GRKs on H1HR regulation, we used small interfering RNAs to selectively target GRK2 and GRK5, two of the primary GRKs expressed in HEK293 cells. A GRK2-specific small interfering RNA effectively reduced GRK2 expression and resulted in a significant increase in histamine-promoted calcium flux. In contrast, knockdown of GRK5 expression was without effect on H1HR signaling. These findings demonstrate that GRK2 is the principal kinase mediating H1 histamine receptor desensitization in HEK293 cells and suggest that rapid termination of H1HR signaling is mediated by both the kinase activity and RGS function of GRK2.
引用
收藏
页码:2197 / 2204
页数:8
相关论文
共 46 条
[1]  
Barnes PJ, 1998, PHARMACOL REV, V50, P515
[2]  
Billington CK, 2003, RESP RES, V4
[3]   Mutational analysis of Gβγ and phospholipid interaction with G protein-coupled receptor kinase 2 [J].
Carman, CV ;
Barak, LS ;
Chen, CG ;
Liu-Chen, LY ;
Onorato, JJ ;
Kennedy, SP ;
Caron, MG ;
Benovic, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :10443-10452
[4]   Selective regulation of Gαq/11 by an RGS domain in the G protein-coupled receptor kinase, GRK2 [J].
Carman, CV ;
Parent, JL ;
Day, PW ;
Pronin, AN ;
Sternweis, PM ;
Wedegaertner, PB ;
Gilman, AG ;
Benovic, JL ;
Kozasa, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :34483-34492
[5]   Endocytosis of G protein-coupled receptors:: roles of G protein-coupled receptor kinases and β-arrestin proteins [J].
Claing, A ;
Laporte, SA ;
Caron, MG ;
Lefkowitz, RJ .
PROGRESS IN NEUROBIOLOGY, 2002, 66 (02) :61-79
[6]   G protein-coupled receptor kinase 2 regulator of G protein signaling homology domain binds to both metabotropic glutamate receptor 1a and Gαq to attenuate signaling [J].
Dhami, GK ;
Dale, LB ;
Anborgh, PH ;
O'Connor-Halligan, KE ;
Sterne-Marr, R ;
Ferguson, SSG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) :16614-16620
[7]   Phosphorylation-independent regulation of metabotropic glutamate receptor signaling by G protein-coupled receptor kinase 2 [J].
Dhami, GK ;
Anborgh, PH ;
Dale, LB ;
Sterne-Marr, R ;
Ferguson, SSG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) :25266-25272
[8]   Phosphorylation-independent inhibition of parathyroid hormone receptor signaling by G protein-coupled receptor kinases [J].
Dicker, F ;
Quitterer, U ;
Winstel, R ;
Honold, K ;
Lohse, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5476-5481
[9]  
Ferguson SSG, 2001, PHARMACOL REV, V53, P1
[10]  
Fujimoto K, 1999, MOL PHARMACOL, V55, P735